Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas. | BMC Cancer | 2023 | 37488496 | PubTator, text mining | PubMed |
| The effects of statin therapy on brain tumors, particularly glioma: a review. | Anticancer Drugs | 2023 | 37466094 | PubTator, text mining | PubMed |
Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Transgenic Alzheimer's Disease Mice. | Int J Mol Sci | 2023 | 37446191 | PubTator, text mining | PubMed |
| Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome. | Int J Mol Sci | 2023 | 37445796 | PubTator, text mining | PubMed |
Dietary Supplements Containing Oat Beta-Glucan and/or Green Coffee (Poly)phenols Showed Limited Effect in Modulating Cardiometabolic Risk Biomarkers in Overweight/Obese Patients without a Lifestyle Intervention. | Nutrients | 2023 | 37432380 | PubTator, text mining | PubMed |
| Cellular Exposure to Chloroacetanilide Herbicides Induces Distinct Protein Destabilization Profiles. | ACS Chem Biol | 2023 | 37427419 | PubTator, text mining | PubMed |
| The NLRP11 Protein Bridges the Histone Lysine Acetyltransferase KAT7 to Acetylate Vimentin in the Early Stage of Lung Adenocarcinoma. | Adv Sci (Weinh) | 2023 | 37424170 | PubTator, text mining | PubMed |
| More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy. | Acta Neuropathol | 2023 | 37421475 | PubTator, text mining | PubMed |
| The regulatory role of lipophagy in central nervous system diseases. | Cell Death Discov | 2023 | 37414782 | PubTator, text mining | PubMed |
| MOBILE pipeline enables identification of context-specific networks and regulatory mechanisms. | Nat Commun | 2023 | 37414767 | PubTator, text mining | PubMed |
| Predictive and prognostic role of early apolipoprotein A-I alteration in recurrent or metastatic nasopharyngeal carcinoma patients treated with anti-PD-1 therapy. | Cancer Med | 2023 | 37409613 | PubTator, text mining | PubMed |
| Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy. | Front Oncol | 2023 | 37409263 | PubTator, text mining | PubMed |
| Aberrant cholesterol metabolism in colorectal cancer represents a targetable vulnerability. | Genes Dis | 2023 | 37397513 | PubTator, text mining | PubMed |
| Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies. | Front Immunol | 2023 | 37388737 | PubTator, text mining | PubMed |
| Iron deficiency is related to lower muscle mass in community-dwelling individuals and impairs myoblast proliferation. | J Cachexia Sarcopenia Muscle | 2023 | 37386912 | PubTator, text mining | PubMed |
| Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis. | Front Cardiovasc Med | 2023 | 37378396 | PubTator, text mining | PubMed |
| Chlorogenic Acid Induced Neuroblastoma Cells Differentiation via the ACAT1-TPK1-PDH Pathway. | Pharmaceuticals (Basel) | 2023 | 37375824 | PubTator, text mining | PubMed |
| Reviewing Atrial Fibrillation Pathophysiology from a Network Medicine Perspective: The Relevance of Structural Remodeling, Inflammation, and the Immune System. | Life (Basel) | 2023 | 37374146 | PubTator, text mining | PubMed |
| Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37373553 | PubTator, text mining | PubMed |
| The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective. | Biomolecules | 2023 | 37371492 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=15